[1]
“N-Myristoyltransferases as antileishmanial targets: a piggyback approach with benzoheterocyclic analogues”,
Braz. J. Pharm. Sci.
, vol. 55, p. e18087, Dec. 2019,
doi: 10.1590/s2175-97902019000218087.